Eyal Kedar

MedicineSocial SciencesImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19”.

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

medRxiv(2022)10.1101/2022.09.22.22280245

N/A

0.464DataRank · unranked

9 citations

Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez +38 more

Type I IFN induces long-chain acyl-CoA synthetase 1 to generate a phosphatidic acid reservoir for lipotoxic saturated fatty acids

Journal of Lipid Research(2024)10.1016/j.jlr.2024.100730

N/A

0.292DataRank · unranked

6 citations

Masami Shimizu‐Albergine, Eyal Kedar, Vishal Kothari, Baohai Shao, Melissa A. Krueger +17 more

Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial

Journal of Clinical and Translational Science(2025)10.1017/cts.2025.10208

N/A

0DataRank · unranked

1 citations

Dima Dandachi, Alexis Bryant, Kevin J. Anstrom, William G. Powderly, Eyal Kedar